# Delivery Order #15B10627F00000001

McKesson Awarded Delivery Order for Specialty Biologics Under VA Pharmaceutical Contract

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $110,804.40
**Ceiling:** $110,804.40

**Awarded:** October 23, 2026
**Period of Performance:** Oct 23, 2026 - Oct 23, 2026

**Identifier:** 15B10627F00000001
**NAICS:** 325412

This award is a delivery order contract awarded to McKesson Corporation, a leading pharmaceutical distribution company, under the larger Pharmaceutical Prime Vendor Contract (PPV) with the Department of Veterans Affairs (VA). The award specifically covers the procurement of specialty biologic medications, representing one option year within a substantial long-term IDV contract aimed at ensuring continuous supply of critical pharmaceuticals to veterans. The contract supports the VA's mission to provide timely access to necessary medications, improving healthcare outcomes for the veteran community. The delivery order involves funding for a specified quarter within the option year timeline and reflects ongoing supplementation of the prime contract, demonstrating the dynamic nature of pharmaceutical supply needs. This contract was awarded as a continuation of the existing competitive prime vendor agreement with McKesson, ensuring consistency and reliability in medication delivery. The performance is scheduled for a short-term period within the specified option year. No subcontractor information or original solicitation details are available for this award.

### Description

BIOLOGICS BY MCKESSON- SPECIALTY MEDICATION CONTRACT #: 36W79720D0001 *OPTION YEAR 3* DOS: OCTOBER 1, 2026- SEPTEMBER 30, 2027 JUSTIFICATION: ADD FUNDING FOR QUARTER 1 (OCT 1- DEC 11)

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B10627F00000001_1540_36W79720D0001_3600)
